Your browser doesn't support javascript.
loading
[Five-year survival prognosis factors in patients with resectable advanced serosa exposed gastric carcinoma]. / Factores pronósticos de sobrevida quinquenal de pacientes con carcinoma gástrico avanzado resecable con serosa expuesta.
Yan-Quiroz, Edgar Fermín; Díaz-Plasencia, Juan Alberto; Burgos-Chávez, Othoniel Abelardo; Rojas-Vergara, Adrián Manuel; Santillán-Medina, Juan; Vilela-Guillén, Edwin Stewart; Balmaceda-Fraselle, Thierry.
Afiliação
  • Yan-Quiroz EF; Prácticas del Curso de Morfofisiología de la Facultad de Medicina de la Universidad Privada.
Rev Gastroenterol Peru ; 23(3): 184-91, 2003.
Article em Es | MEDLINE | ID: mdl-14532919
PURPOSE: To identify the main five-year survival prognosis factors in patients with resectable advanced serosa exposed gastric carcinoma, who have undergone radical gastric resection with limited and extended lymphadenectomy. MATERIAL AND METHODS: This retrospective study examined 137 patients with resectable advanced serosa exposed gastric carcinoma, in the Belén Hospital, Trujillo, Peru, between 1991 and 2000. RESULTS: The average age of the total series was 58.1 +/- 14.8 year (ranging from 20 to 84 years). This series was formed by 137 patients, of which 77 (56.2%) were male and 60 (43.8%) were female (M:F ratio=1.3:1). The univariate analysis using the log-rank test, showed that the following variables were significantly associated with five-year survival: lack of palpable mass (p=0.0308), serum haemoglobin concentration of 10 g/dl or higher (p=0.05) neoplasias located in the distal third of the stomach (p=0.0001) regional ganglionic condition N0-N1 (p=0.03), clinical stage II (p=0.0327) ganglionic dissection D2-D3 (p=0.0366) and curative intended surgery (p=0.000). The actual survival rate of the entire series after 5 years was of 16.3%. In the group subjected to lymphadenectomy D0-D1 (n=105) survival rate after 5 years was of 12.6%, while in the group subjected to D2-D3 (n=32) it was of 30.2% (p=0.0366). Five-year survival rate in patients who underwent curative intended surgery (n=56) was of 33.4% and those who had palliative surgery (n=81) had a five-year survival rate of 3.1% (p=0.000). CONCLUSIONS: Early detection, availability of curative surgery and the use of extended lymphadenectomy are factors that have an influence on the survival rate. These parameters should be considered for the staging of patients and their subsequent post-surgery assisting treatment.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Mucosa Gástrica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: Es Revista: Rev Gastroenterol Peru Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2003 Tipo de documento: Article País de publicação: Peru
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Mucosa Gástrica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: Es Revista: Rev Gastroenterol Peru Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2003 Tipo de documento: Article País de publicação: Peru